BioCentury | Jan 7, 2013
Company News

OvaScience management update

...Alison Lawton as COO, formerly SVP and general manager of the Sanofi Biosurgery division (formerly Genzyme Biosurgery...
BioCentury | Dec 5, 2011
Company News

GI Dynamics management update

...as chief commercial officer, a newly created position, formerly SVP and general manager of the Genzyme Biosurgery...
BioCentury | Feb 21, 2011
Strategy

BioMarin wants control

BioMarin Pharmaceutical Inc. hopes to use the acquisition of partner Genzyme Corp. (NASDAQ:GENZ) by sanofi-aventis Group (Euronext:SAN; NYSE:SNY) as the occasion to reacquire full rights to Aldurazyme laronidase, which would be its second-largest revenue generator....
BioCentury | Sep 6, 2010
Strategy

Laying siege

sanofi-aventis Group made clear in its conference call last week that it's in no hurry to complete its proposed acquisition of Genzyme Corp. - with the obvious implication that time is on its side. If so,...
BioCentury | May 10, 2010
Finance

The gloves are off

Carl Icahn finally made it crystal clear that his goal in his battle with Genzyme Corp. is to depose Chairman, President and CEO Henri Termeer. A few days in advance of the company's analyst and...
BioCentury | Nov 8, 2004
Company News

Genzyme, Wyeth sales and marketing update

...next year. WYE obtained rights to Synvisc in 1997 from Biomatrix , which merged into Genzyme Biosurgery...
BioCentury | Jul 7, 2003
Company News

Genzyme Bio, Genzyme, Genzyme General, Genzyme Molecular deal

...completing Genzyme's previously announced elimination of the company's tracking stock structure (see BioCentury, May 12). Genzyme Biosurgery...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...An NDA is slated for the first half of next year. Ebb & Flow Genzyme Biosurgery...
BioCentury | Jun 9, 2003
Company News

Genzyme General Corp., Genzyme Biosurgery Inc. biopharmaceuticals news

...and Genzyme Molecular Oncology (see BioCentury Extra, May 8). Genzyme General Corp. (GENZ), Cambridge, Mass. Genzyme Biosurgery...
BioCentury | Jun 3, 2003
Top Story

GZBX consolidation opposed

Genzyme Biosurgery (GZBX) shareholders Rory Riggs and John Lewis filed suit in the U.S. District Court for the Southern District of New York seeking to block the sale of GZBX stock to Genzyme (GENZ). The...
Items per page:
1 - 10 of 53
BioCentury | Jan 7, 2013
Company News

OvaScience management update

...Alison Lawton as COO, formerly SVP and general manager of the Sanofi Biosurgery division (formerly Genzyme Biosurgery...
BioCentury | Dec 5, 2011
Company News

GI Dynamics management update

...as chief commercial officer, a newly created position, formerly SVP and general manager of the Genzyme Biosurgery...
BioCentury | Feb 21, 2011
Strategy

BioMarin wants control

BioMarin Pharmaceutical Inc. hopes to use the acquisition of partner Genzyme Corp. (NASDAQ:GENZ) by sanofi-aventis Group (Euronext:SAN; NYSE:SNY) as the occasion to reacquire full rights to Aldurazyme laronidase, which would be its second-largest revenue generator....
BioCentury | Sep 6, 2010
Strategy

Laying siege

sanofi-aventis Group made clear in its conference call last week that it's in no hurry to complete its proposed acquisition of Genzyme Corp. - with the obvious implication that time is on its side. If so,...
BioCentury | May 10, 2010
Finance

The gloves are off

Carl Icahn finally made it crystal clear that his goal in his battle with Genzyme Corp. is to depose Chairman, President and CEO Henri Termeer. A few days in advance of the company's analyst and...
BioCentury | Nov 8, 2004
Company News

Genzyme, Wyeth sales and marketing update

...next year. WYE obtained rights to Synvisc in 1997 from Biomatrix , which merged into Genzyme Biosurgery...
BioCentury | Jul 7, 2003
Company News

Genzyme Bio, Genzyme, Genzyme General, Genzyme Molecular deal

...completing Genzyme's previously announced elimination of the company's tracking stock structure (see BioCentury, May 12). Genzyme Biosurgery...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...An NDA is slated for the first half of next year. Ebb & Flow Genzyme Biosurgery...
BioCentury | Jun 9, 2003
Company News

Genzyme General Corp., Genzyme Biosurgery Inc. biopharmaceuticals news

...and Genzyme Molecular Oncology (see BioCentury Extra, May 8). Genzyme General Corp. (GENZ), Cambridge, Mass. Genzyme Biosurgery...
BioCentury | Jun 3, 2003
Top Story

GZBX consolidation opposed

Genzyme Biosurgery (GZBX) shareholders Rory Riggs and John Lewis filed suit in the U.S. District Court for the Southern District of New York seeking to block the sale of GZBX stock to Genzyme (GENZ). The...
Items per page:
1 - 10 of 53